Progressive pulmonary fibrosis is not a diagnosis so much as a disease behavior and a clinical phenotype, says Anna-Maria ...

It has been 10 years since the first biosimilar was approved by the FDA. The grades on how the market for biosimilars has ...

Esophageal squamous cell carcinoma accounts for approximately 90% of all esophageal cancer cases. Projections estimate that ...

Few question the benefits of adopting a universal healthcare data exchange standard but achieving that goal will prove to be ...

New research could pave the way toward a new method of pulmonary arterial hypertension diagnosis and monitoring.

In a small study in a community oncology practice, more than 60% of patients with advanced squamous cell skin cancer treated ...

Facing a variety of financial pressures, health plans need to take a measured approach to identify supplemental benefit ...

Approximately 70 minutes into the address, President Donald Trump mentioned rising childhood cancer rates and the prevalence ...

The researchers found that factors favoring chemoimmunotherapy included higher socioeconomic status, being uninsured, a more ...

Environmental factors like diet and early antibiotic use have an impact on the gut microbiome and can contribute to inflammatory bowel disease (IBD), explained Ashwin N. Ananthakrishnan, M.D., M.P.H., ...

NovoCare Pharmacy will provide all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients without insurance.

Drugs in late-stage development may mean competition on price for two Pfizer medications that, by some accounts, are the most expensive cardiac medications in history.